Patents by Inventor Carlota Vinals y de Bassols

Carlota Vinals y de Bassols has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Tumor specific animal proteins
    Patent number: 8535690
    Abstract: CASB7439 polypeptides and polynucleotides, immunogenic compositions comprising them and methods for producing such polypeptides by recombinant techniques are disclosed. Also disclosed are methods for utilizing CASB7439 polypeptides and polynucleotides in diagnostics, and vaccines for prophylactic and therapeutic treatment of cancers, particularly colorectal cancers, autoimmune diseases, and related conditions.
    Type: Grant
    Filed: May 15, 2012
    Date of Patent: September 17, 2013
    Assignee: GlaxoSmithKline Biologicals S.A.
    Inventors: Teresa Elisa Virginia Cabezon-Silva, Jean-Pol Cassart, Thierry Coche, Swann Romain Jean-Thomas Gaulis, Carlota Vinals Y De Bassols
  • TUMOR SPECIFIC ANIMAL PROTEINS
    Publication number: 20120244175
    Abstract: CASB7439 polypeptides and polynucleotides, immunogenic compositions comprising them and methods for producing such polypeptides by recombinant techniques are disclosed. Also disclosed are methods for utilizing CASB7439 polypeptides and polynucleotides in diagnostics, and vaccines for prophylactic and therapeutic treatment of cancers, particularly colorectal cancers, autoimmune diseases, and related conditions.
    Type: Application
    Filed: May 15, 2012
    Publication date: September 27, 2012
    Inventors: Teresa Elisa Virginia CABEZON-SILVA, Jean-Pol Cassart, Thierry Coche, Swann Romain Jean-Thomas Gaulis, Carlota Vinals Y De Bassols
  • Tumour-specific animal proteins
    Patent number: 8207123
    Abstract: CASB7439 polypeptides and polynucleotides, immunogenic compositions comprising them and methods for producing such polypeptides by recombinant techniques are disclosed. Also disclosed are methods for utilizing CASB7439 polypeptides and polynucleotides in diagnostics, and vaccines for prophylactic and therapeutic treatment of cancers, particularly colorectal cancers, autoimmune diseases, and related conditions.
    Type: Grant
    Filed: August 20, 2010
    Date of Patent: June 26, 2012
    Assignee: GlaxoSmithKline Biologicals S.A.
    Inventors: Teresa Elisa Virginia Cabezon-Silva, Jean-Pol Cassart, Thierry Coche, Swann Romain Jean-Thomas Gaulis, Carlota Vinals Y De Bassols
  • TUMOUR-SPECIFIC ANIMAL PROTEINS
    Publication number: 20110052615
    Abstract: CASB7439 polypeptides and polynucleotides, immunogenic compositions comprising them and methods for producing such polypeptides by recombinant techniques are disclosed. Also disclosed are methods for utilizing CASB7439 polypeptides and polynucleotides in diagnostics, and vaccines for prophylactic and therapeutic treatment of cancers, particularly colorectal cancers, autoimmune diseases, and related conditions.
    Type: Application
    Filed: August 20, 2010
    Publication date: March 3, 2011
    Inventors: TERESA ELISA VIRGINIA CABEZON-SILVA, JEAN-POL CASSART, THIERRY COCHE, SWANN ROMAIN JEAN-THOMAS GAULIS, CARLOTA VINALS Y DE BASSOLS
  • Tumour-Specific Animal Proteins
    Publication number: 20100291121
    Abstract: CASB7439 polypeptides and polynucleotides, immunogenic compositions comprising them and methods for producing such polypeptides by recombinant techniques are disclosed. Also disclosed are methods for utilizing CASB7439 polypeptides and polynucleotides in diagnostics, and vaccines for prophylactic and therapeutic treatment of cancers, particularly colorectal, breast, and lung cancers, autoimmune diseases, and related conditions.
    Type: Application
    Filed: March 9, 2009
    Publication date: November 18, 2010
    Inventors: Jean-Pol Cassart, Teresa Elisa Virginia Cabezon-Silva, Thierry Coche, Swann Romain Jean-Thomas Gaulis, Carlota Vinals Y De Bassols
  • Tumour-specific animal proteins
    Patent number: 7811574
    Abstract: CASB7439 polypeptides and polynucleotides, immunogenic compositions comprising them and methods for producing such polypeptides by recombinant techniques are disclosed. Also disclosed are methods for utilizing CASB7439 polypeptides and polynucleotides in diagnostics, and vaccines for prophylactic and therapeutic treatment of cancers, particularly colorectal, breast, and lung cancers, autoimmune diseases, and related conditions.
    Type: Grant
    Filed: August 28, 2003
    Date of Patent: October 12, 2010
    Assignee: GlaxoSmithKline Biologicals S.A.
    Inventors: Jean-Pol Cassart, Teresa Elisa Virginia Cabezon-Silva, Thierry Coche, Swann Romain Jean-Thomas Gaulis, Carlota Vinals Y De Bassols
  • Tumour-specific animal proteins
    Patent number: 7803379
    Abstract: CASB7439 polypeptides and polynucleotides, immunogenic compositions comprising them and methods for producing such polypeptides by recombinant techniques are disclosed. Also disclosed are methods for utilizing CASB7439 polypeptides and polynucleotides in diagnostics, and vaccines for prophylactic and therapeutic treatment of cancers, particularly colorectal cancers, autoimmune diseases, and related conditions.
    Type: Grant
    Filed: December 13, 2005
    Date of Patent: September 28, 2010
    Assignee: GlaxoSmithKline Biologicals S.A.
    Inventors: Teresa Elisa Virginia Cabezon-Silva, Jean-Pol Cassart, Thierry Coche, Swann Romain Jean-Thomas Gaulis, Carlota Vinals Y De Bassols
  • BASB027 PROTEINS AND GENES FROM MORAXELLA CATARRHALIS, ANTIGENS, ANTIBODIES, AND USES
    Publication number: 20100143412
    Abstract: The invention provides BASB027 polypeptides and polynucleotides encoding BASB027 polypeptides and methods for producing such polypeptides by recombinant techniques. Also provided are diagnostic, prophylactic and therapeutic uses.
    Type: Application
    Filed: November 18, 2009
    Publication date: June 10, 2010
    Applicant: GLAXOSMITHKLINE BIOLOGICALS S.A.
    Inventor: Carlota Vinals y de Bassols
  • BASB027 proteins and genes from , antigens, antibodies, and uses
    Patent number: 7641910
    Abstract: The invention provides BASB027 polypeptides and polynucleotides encoding BASB027 polypeptides and methods for producing such polypeptides by recombinant techniques. Also provided are diagnostic, prophylactic and therapeutic uses.
    Type: Grant
    Filed: July 22, 2004
    Date of Patent: January 5, 2010
    Assignee: GlaxoSmithKline Biologicals S.A.
    Inventor: Carlota Vinals y de Bassols
  • CASB618 Polynucleotides and Polypeptides and Their Use
    Publication number: 20090202577
    Abstract: CASB618 polypeptides and polynucleotides and methods for producing such polypeptides by recombinant techniques are disclosed. Also disclosed are methods for utilizing CASB618 polypeptides and polynucleotides in diagnostics, and vaccines for prophylactic and therapeutic treatment of cancers, particularly ovarian and colon cancers, autoimmune diseases, and related conditions.
    Type: Application
    Filed: November 21, 2008
    Publication date: August 13, 2009
    Inventors: CLAUDINE ELVIRE BRUCK, JEAN-POL CASSART, THIERRY COCHE, CARLOTA VINALS Y DE BASSOLS
  • CASB618 polynucleotides and polypeptides and their use
    Patent number: 7470782
    Abstract: CASB618 polypeptides and polynucleotides and methods for producing such polypeptides by recombinant techniques are disclosed. Also disclosed are methods for utilizing CASB618 polypeptides and polynucleotides in diagnostics, and vaccines for prophylactic and therapeutic treatment of cancers, particularly ovarian and colon cancers, autoimmune diseases, and related conditions.
    Type: Grant
    Filed: August 9, 2005
    Date of Patent: December 30, 2008
    Assignee: GlaxoSmithKline Biologicals, S.A.
    Inventors: Claudine Elvire Marie Bruck, Jean-Pol Cassart, Thierry Coche, Carlota Vinals Y De Bassols
  • Cripto tumour polypeptide
    Patent number: 7439320
    Abstract: Compositions and methods for the therapy and diagnosis of cancer, particularly lung, colon, colorectal and breast cancer, are disclosed. Illustrative compositions comprise one or more Cripto tumor polypeptides, immunogenic portions thereof, polynucleotides that encode such polypeptides, antigen presenting cell that expresses such polypeptides, and T cells that are specific for cells expressing such polypeptides. The disclosed compositions are useful, for example, in the diagnosis, prevention and/or treatment of diseases, particularly lung, colon, colorectal and breast cancer.
    Type: Grant
    Filed: August 20, 2001
    Date of Patent: October 21, 2008
    Assignee: GlaxoSmith Kline Biologicals s.a.
    Inventors: Jean-Pol Cassart, Thierry Coche, Remi M Palmantier, Carlota Vinals Y De Bassols
  • Vaccines
    Publication number: 20080249013
    Abstract: Compositions and methods for the therapy and diagnosis of cancer, particularly lung, colon, colorectal and breast cancer, are disclosed. Illustrative compositions comprise one or more Cripto tumor polypeptides, immunogenic portions thereof, polynucleotides that encode such polypeptides, antigen presenting cell that expresses such polypeptides, and T cells that are specific for cells expressing such polypeptides. The disclosed compositions are useful, for example, in the diagnosis, prevention and/or treatment of diseases, particularly lung, colon, colorectal and breast cancer.
    Type: Application
    Filed: January 29, 2008
    Publication date: October 9, 2008
    Applicant: GLAXOSMITHKLINE BIOLOGICALS SA
    Inventors: Teresa Elisa Virginia Silva CABEZON, Catherine Marie Ghislaine GERARD, Remi M. PALMANTIER, Carlota VINALS Y DE BASSOLS
  • Compositions and methods for the therapy and diagnosis of prostate cancer
    Publication number: 20060269532
    Abstract: Compositions and methods for the therapy and diagnosis of cancer, particularly prostate cancer, are disclosed. Illustrative compositions comprise one or more prostate-specific polypeptides, immunogenic portions thereof, polynucleotides that encode such polypeptides, antigen presenting cell that expresses such polypeptides, and T cells that are specific for cells expressing such polypeptides. The disclosed compositions are useful, for example, in the diagnosis, prevention and/or treatment of diseases, particularly prostate cancer.
    Type: Application
    Filed: February 1, 2006
    Publication date: November 30, 2006
    Applicant: Corixa Corporation
    Inventors: Jiangchun Xu, Davin Dillon, Jennifer Mitcham, Susan Harlocker, Yuqiu Jiang, Robert Henderson, Michael Kalos, Gary Fanger, Marc Retter, John Stolk, Craig Day, Thomas Vedvick, Darrick Carter, Samuel Li, Aijun Wang, Yasir Skeiky, William Hepler, John Hural, Patricia McNeill, Raymond Houghton, Carlota Vinals y de Bassols, Teresa Foy, Yoshihiro Watanabe, Madeleine Meagher, Ta Deng
  • Tumour-specific animal proteins
    Publication number: 20060171953
    Abstract: CASB7439 polypeptides and polynucleotides, immunogenic compositions comprising them and methods for producing such polypeptides by recombinant techniques are disclosed. Also disclosed are methods for utilizing CASB7439 polypeptides and polynucleotides in diagnostics, and vaccines for prophylactic and therapeutic treatment of cancers, particularly colorectal cancers, autoimmune diseases, and related conditions.
    Type: Application
    Filed: December 13, 2005
    Publication date: August 3, 2006
    Inventors: Teresa Cabezon-Silva, Jean-Pol Cassart, Thierry Coche, Swann Romain Gaulis, Carlota Vinals Y De Bassols
  • Prostate-specific polynucleotide compositions
    Patent number: 7033827
    Abstract: Compositions and methods for the therapy and diagnosis of cancer, particularly prostate cancer, are disclosed. Illustrative compositions comprise one or more prostate-specific polypeptides, immunogenic portions thereof, polynucleotides that encode such polypeptides, antigen presenting cell that expresses such polypeptides, and T cells that are specific for cells expressing such polypeptides. The disclosed compositions are useful, for example, in the diagnosis, prevention and/or treatment of diseases, particularly prostate cancer.
    Type: Grant
    Filed: May 9, 2002
    Date of Patent: April 25, 2006
    Assignee: Corixa Corporation
    Inventors: Jiangchun Xu, Davin C. Dillon, Jennifer L. Mitcham, Susan L. Harlocker, Yuqiu Jiang, Robert A. Henderson, Michael D. Kalos, Gary R. Fanger, Marc W. Retter, John A. Stolk, Craig H. Day, Thomas S. Vedvick, Darrick Carter, Samuel X. Li, Aijun Wang, Yasir A. W. Skeiky, William T. Hepler, John Hural, Patricia D. McNeill, Raymond L. Houghton, Carlota Vinals y de Bassols, Teresa M. Foy, Yoshihiro Watanabe, Madeleine Joy Meagher, Ta Deng
  • CASB618 polynucleotides and polypeptides and their use
    Publication number: 20060052593
    Abstract: CASB618 polypeptides and polynucleotides and methods for producing such polypeptides by recombinant techniques are disclosed. Also disclosed are methods for utilizing CASB618 polypeptides and polynucleotides in diagnostics, and vaccines for prophylactic and therapeutic treatment of cancers, particularly ovarian and colon cancers, autoimmune diseases, and related conditions.
    Type: Application
    Filed: August 9, 2005
    Publication date: March 9, 2006
    Inventors: Claudine Bruck, Jean-Pol Cassart, Thierry Coche, Carlota Vinals Y De Bassols
  • Compositions and methods for the therapy and diagnosis of prostate cancer
    Patent number: 6943236
    Abstract: Compositions and methods for the therapy and diagnosis of cancer, particularly prostate cancer, are disclosed. Illustrative compositions comprise one or more prostate-specific polypeptides, immunogenic portions thereof, polynucleotides that encode such polypeptides, antigen presenting cell that expresses such polypeptides, and T cells that are specific for cells expressing such polypeptides. The disclosed compositions are useful, for example, in the diagnosis, prevention and/or treatment of diseases, particularly prostate cancer.
    Type: Grant
    Filed: December 10, 2001
    Date of Patent: September 13, 2005
    Assignee: Corixa Corporation
    Inventors: Jiangchun Xu, Davin C. Dillon, Jennifer L. Mitcham, Susan L. Harlocker, Yuqiu Jiang, Michael D. Kalos, Gary R. Fanger, Marc W. Retter, John A. Stolk, Craig H. Day, Thomas S. Vedvick, Darrick Carter, Samuel X. Li, Aijun Wang, Yasir A. W. Skeiky, William T. Hepler, Robert A. Henderson, John Hural, Patricia D. McNeill, Raymond L. Houghton, Carlota Vinals y de Bassols, Teresa M. Foy, Yoshihiro Watanabe, Madeleine Joy Meagher
  • BASB027 proteins and genes from moraxella catarrhalis, antigens, antibodies, and uses
    Publication number: 20040265331
    Abstract: The invention provides BASB027 polypeptides and polynucleotides encoding BASB027 polypeptides and methods for producing such polypeptides by recombinant techniques. Also provided are diagnostic, prophylactic and therapeutic uses.
    Type: Application
    Filed: July 22, 2004
    Publication date: December 30, 2004
    Applicant: SmithKline Beecham Biologicals S.A.
    Inventor: Carlota Vinals y de Bassols
  • Vaccines
    Publication number: 20040202648
    Abstract: Compositions and methods for the therapy and diagnosis of cancer, particularly lung, colon, colorectal and breast cancer, are disclosed. Illustrative compositions comprise one or more Cripto tumor polypeptides, immunogenic portions thereof, polynucleotides that encode such polypeptides, antigen presenting cell that expresses such polypeptides, and T cells that are specific for cells expressing such polypeptides. The disclosed compositions are useful, for example, in the diagnosis, prevention and/or treatment of diseases, particularly lung, colon, colorectal and breast cancer.
    Type: Application
    Filed: April 1, 2004
    Publication date: October 14, 2004
    Inventors: Teresa Elisa Virgina Silva Cabezon, Catherine Marie Ghislaine Gerard, Remi M. Palmantier, Carlota Vinals Y De Bassols